NEW YORK ( TheStreet) -- Quest Diagnostics (NYSE: DGX) hit a new 52-week high Thursday as it is currently trading at $59.77, above its previous 52-week high of $59.75 with 430,056 shares traded as of 10:41 a.m. ET. Average volume has been 1.5 million shares over the past 30 days.

Quest has a market cap of $9.4 billion and is part of the health care sector and health services industry. Shares are up 9.9% year to date as of the close of trading on Wednesday.

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company has a P/E ratio of 21, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7.
  • Practice your DGX trading strategies and win cash in our stock game.

TheStreet Ratings rates Quest as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Quest Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.